Drug Shortage Report for MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL

Last updated on 2019-06-18 History
Report ID 82201
Drug Identification Number 02443902
Brand name MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Common or Proper name EMTRICITABINE/TENOFOVIR DISOPROXIL
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE
Strength(s) 300MG 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BT
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2019-06-06
Actual start date 2019-06-11
Estimated end date 2019-07-30
Actual end date
Shortage status Actual shortage
Updated date 2019-06-18
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2019-06-18 French Compare
v23 2019-06-18 English Compare
v22 2019-06-07 English Compare
v21 2019-06-04 French Compare
v20 2019-06-04 English Compare
v19 2019-06-01 English Compare
v18 2019-05-28 French Compare
v17 2019-05-28 English Compare
v16 2019-05-28 French Compare
v15 2019-05-28 English Compare
v14 2019-05-25 English Compare
v13 2019-05-22 French Compare
v12 2019-05-22 English Compare
v11 2019-05-21 English Compare
v10 2019-05-14 French Compare
v9 2019-05-14 English Compare
v8 2019-05-08 French Compare
v7 2019-05-08 English Compare
v6 2019-05-01 English Compare
v5 2019-04-30 French Compare

Showing 1 to 20 of 24